RETRACTED: miR-140-3p Inhibits Cutaneous Melanoma Progression by Disrupting AKT/p70S6K and JNK Pathways through ABHD2

Trotter, 2013, A Global Review of Melanoma Follow-up Guidelines, J. Clin. Aesthet. Dermatol., 6, 18 Flaherty, 2012, Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations, N. Engl. J. Med., 367, 1694, 10.1056/NEJMoa1210093 Wolchok, 2013, Nivolumab plus ipilimumab in advanced melanoma, N. Engl. J. Med., 369, 122, 10.1056/NEJMoa1302369 Strickland, 2015, Targeting drivers of melanoma with synthetic small molecules and phytochemicals, Cancer Lett., 359, 20, 10.1016/j.canlet.2015.01.016 Eggermont, 2014, Cutaneous melanoma, Lancet, 383, 816, 10.1016/S0140-6736(13)60802-8 Korn, 2008, Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials, J. Clin. Oncol., 26, 527, 10.1200/JCO.2007.12.7837 Long, 2016, Factors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment: a pooled analysis of individual patient data from randomised trials, Lancet Oncol., 17, 1743, 10.1016/S1470-2045(16)30578-2 Nicoloso, 2009, MicroRNAs—the micro steering wheel of tumour metastases, Nat. Rev. Cancer, 9, 293, 10.1038/nrc2619 Tavakolizadeh, 2018, MicroRNAs and exosomes in depression: Potential diagnostic biomarkers, J. Cell. Biochem., 119, 3783, 10.1002/jcb.26599 Saeedi Borujeni, 2018, Molecular aspects of diabetes mellitus: Resistin, microRNA, and exosome, J. Cell. Biochem., 119, 1257, 10.1002/jcb.26271 Mirzaei, 2017, Cytokines and MicroRNA in Coronary Artery Disease, Adv. Clin. Chem., 82, 47, 10.1016/bs.acc.2017.06.004 Keshavarzi, 2017, MicroRNAs-Based Imaging Techniques in Cancer Diagnosis and Therapy, J. Cell. Biochem., 118, 4121, 10.1002/jcb.26012 Ross, 2018, MicroRNAs in cutaneous melanoma: Role as diagnostic and prognostic biomarkers, J. Cell. Physiol., 233, 5133, 10.1002/jcp.26395 Mirzaei, 2016, MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma, Eur. J. Cancer, 53, 25, 10.1016/j.ejca.2015.10.009 Segura, 2012, MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy, Carcinogenesis, 33, 1823, 10.1093/carcin/bgs205 Kozomara, 2014, miRBase: annotating high confidence microRNAs using deep sequencing data, Nucleic Acids Res., 42, D68, 10.1093/nar/gkt1181 Zhang, 2019, Upregulation of microRNA-140-3p inhibits epithelial-mesenchymal transition, invasion, and metastasis of hepatocellular carcinoma through inactivation of the MAPK signaling pathway by targeting GRN, J. Cell. Biochem., 120, 14885, 10.1002/jcb.28750 Bhardwaj, 2018, The isomiR-140-3p-regulated mevalonic acid pathway as a potential target for prevention of triple negative breast cancer, Breast Cancer Res., 20, 150, 10.1186/s13058-018-1074-z Jin, 2009, Age-related pulmonary emphysema in mice lacking alpha/beta hydrolase domain containing 2 gene, Biochem. Biophys. Res. Commun., 380, 419, 10.1016/j.bbrc.2009.01.098 Miyata, 2008, Elevated mature macrophage expression of human ABHD2 gene in vulnerable plaque, Biochem. Biophys. Res. Commun., 365, 207, 10.1016/j.bbrc.2007.10.127 Obinata, 2016, Abhydrolase domain containing 2, an androgen target gene, promotes prostate cancer cell proliferation and migration, Eur. J. Cancer, 57, 39, 10.1016/j.ejca.2016.01.002 Corrie, 2014, Management of melanoma, Br. Med. Bull., 111, 149, 10.1093/bmb/ldu019 Mirzaei, 2018, The therapeutic potential of human adipose-derived mesenchymal stem cells producing CXCL10 in a mouse melanoma lung metastasis model, Cancer Lett., 419, 30, 10.1016/j.canlet.2018.01.029 Mirzaei, 2016, Application of Mesenchymal Stem Cells in Melanoma: A Potential Therapeutic Strategy for Delivery of Targeted Agents, Curr. Med. Chem., 23, 455, 10.2174/0929867323666151217122033 Miller, 2019, Cancer treatment and survivorship statistics, 2019, CA Cancer J. Clin., 69, 363, 10.3322/caac.21565 Kapodistrias, 2017, [MiR-140-3p Downregulation in Association with PDL-1 Overexpression in Many Cancers: A Review from the Literature Using Predictive Bioinformatics Tools], Adv. Exp. Med. Biol., 988, 225, 10.1007/978-3-319-56246-9_18 Yin, 2017, Dysregulation of both miR-140-3p and miR-140-5p in synovial fluid correlate with osteoarthritis severity, Bone Joint Res., 6, 612, 10.1302/2046-3758.611.BJR-2017-0090.R1 Karakas, 2017, Circulating microRNAs strongly predict cardiovascular death in patients with coronary artery disease-results from the large AtheroGene study, Eur. Heart J., 38, 516 Cirnigliaro, 2017, Expression and Regulatory Network Analysis of miR-140-3p, a New Potential Serum Biomarker for Autism Spectrum Disorder, Front. Mol. Neurosci., 10, 250, 10.3389/fnmol.2017.00250 Zhou, 2019, miR-140-3p inhibits breast cancer proliferation and migration by directly regulating the expression of tripartite motif 28, Oncol. Lett., 17, 3835 Huang, 2019, miR-140-3p functions as a tumor suppressor in squamous cell lung cancer by regulating BRD9, Cancer Lett., 446, 81, 10.1016/j.canlet.2019.01.007 Giard, 1973, In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors, J. Natl. Cancer Inst., 51, 1417, 10.1093/jnci/51.5.1417 Chee, 1976, Production of melanoma-associated antigen(s) by a defined malignant melanoma cell strain grown in chemically defined medium, Cancer Res., 36, 1503 von Euw, 2012, Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines, Mol. Cancer, 11, 22, 10.1186/1476-4598-11-22 Yu, 2019, Retinoic Acid Induces Differentiation of Mouse F9 Embryonic Carcinoma Cell by Modulating the miR-485 Targeting of Abhd2, Int. J. Mol. Sci., 20, e2071, 10.3390/ijms20092071 Yamanoi, 2016, Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer, Oncotarget, 7, 47620, 10.18632/oncotarget.9951 Jude, 2012, miR-140-3p regulation of TNF-α-induced CD38 expression in human airway smooth muscle cells, Am. J. Physiol. Lung Cell. Mol. Physiol., 303, L460, 10.1152/ajplung.00041.2012 Wu, 2019, miR-140-3p Knockdown Suppresses Cell Proliferation and Fibrogenesis in Hepatic Stellate Cells via PTEN-Mediated AKT/mTOR Signaling, Yonsei Med. J., 60, 561, 10.3349/ymj.2019.60.6.561 Du, 2019, JNK2 Is Required for the Tumorigenic Properties of Melanoma Cells, ACS Chem. Biol., 14, 1426, 10.1021/acschembio.9b00083 Caporali, 2016, Targeting the PI3K/AKT/mTOR pathway overcomes the stimulating effect of dabrafenib on the invasive behavior of melanoma cells with acquired resistance to the BRAF inhibitor, Int. J. Oncol., 49, 1164, 10.3892/ijo.2016.3594 Fenouille, 2012, The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion, PLoS ONE, 7, e40378, 10.1371/journal.pone.0040378 Yun, 2017, Regulation of calcium release from the endoplasmic reticulum by the serine hydrolase ABHD2, Biochem. Biophys. Res. Commun., 490, 1226, 10.1016/j.bbrc.2017.06.195 Avalle, 2019, STAT3 localizes to the ER, acting as a gatekeeper for ER-mitochondrion Ca2+ fluxes and apoptotic responses, Cell Death Differ., 26, 932, 10.1038/s41418-018-0171-y Pinton, 2008, Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis, Oncogene, 27, 6407, 10.1038/onc.2008.308